expert perspectives

in Chronic Graft-versus-Host Disease

Expert Perspectives in Chronic Graft-versus-Host Disease to Cover Key Topics in cGVHD Treatment

Overview

Expert Perspectives delivers health care providers with insights from key thought leaders on the latest advancements and current practices in medicine, in a concise and timely format. This issue of Expert Perspectives in Chronic Graft-versus-Host Disease will feature selected topics in cGVHD that we hope you will find of value in your clinical practice.

The clinicians who were surveyed selected the following experts and topics.

Community-Selected Experts: 

Daniel R. Couriel, MD, MS

Professor of Internal Medicine
HCI Chair for Adult Leukemia Research
Director, Utah Blood and Marrow Transplant Program
Medical Director, Center for Cellular Therapy and Regenerative Medicine
Division of Hematology and Hematologic Malignancies
Huntsman Cancer Institute
University of Utah School of Medicine
Salt Lake City, UT

Corey Cutler, MD, MPH, FRCP(C)

Medical Director, Stem Cell Transplantation Program
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA

Sergio A. Giralt, MD

Deputy Division Head
Division of Hematologic Malignancies
Melvin Berlin Family Chair in Multiple Myeloma
Memorial Sloan Kettering Cancer Center
New York, NY


Community-Selected Topics: 

Expert Roundtables 

    Optimizing the Chronic Graft-versus-Host Disease Treatment Paradigm
    Chronic Graft-versus-Host Disease: Current Challenges and Opportunities
    Refractory Chronic Graft-versus-Host Disease: Management and Monitoring Recommendations
    Preventing and Treating Chronic Graft-versus-Host Disease Without Compromising Antitumor Effects

Clinical Topic Updates 

    Refractory Chronic Graft-versus-Host Disease: Choosing Immunosuppressive/Immunomodulating Agents
    Screening for Chronic Graft-versus-Host Disease–Associated Comorbidities
    Updates on Preventive Measures for Chronic Graft-versus-Host Disease
    Targeting Cytokine Pathways in Chronic Graft-versus-Host Disease: Drivers of Fibrosis and Inflammation

Patient Care Perspectives

    Tailoring Care to Organ-Specific Manifestations of Chronic Graft-versus-Host Disease
    Principles of Multispecialty Care for Refractory Chronic Graft-versus-Host Disease
    Patients With Ongoing Chronic Graft-versus-Host Disease: Tracking and Adjusting Treatment
    Role of Adjunctive Nonsystemic Therapies in Chronic Graft-versus-Host Disease

More in cGVHD

Thumb

cGVHD

Refractory Chronic Graft-versus-Host Disease: Choosing Immunosuppressive and/or Immunomodulating Agents

Clinical Topic Updates by Corey Cutler, MD, MPH, FRCP(C)

Patients with chronic graft-versus-host disease (cGVHD) may require modification of immunosuppression if they have not at least achieved a partial ...READ MORE

Thumb

cGVHD

Screening for Chronic Graft-versus-Host Disease–Associated Comorbidities

Clinical Topic Updates by Sergio A. Giralt, MD

Routine periodic screening for chronic graft-versus-host disease (cGVHD)–associated comorbidities helps to ensure that the manifestations of cGVHD ...READ MORE

Thumb

cGVHD

Principles of Multispecialty Care for Refractory Chronic Graft-versus-Host Disease

Patient Care Perspectives by Daniel R. Couriel, MD, MS

Patients with chronic graft-versus-host disease (cGVHD) benefit from integrated care and specialists who are experienced with their particular need...READ MORE

More In Oncology

MDS & AML

Emerging Immuno Myeloid Therapies In Mds And Aml

Expert Roundtables by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; and Rami S. Komrokji, MD

MDS & AML

Improving Response Durability In High Risk Mds And Aml

Expert Roundtables by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; and Rami S. Komrokji, MD

MDS & AML

Integrating Genomics Into The Classification And Management Of Mds

Expert Roundtables by Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; and Rami S. Komrokji, MD